Cellis AG
Biotechnology · Zug, Zug
Cellis AG is a Swiss biotechnology company based in Zug, Canton of Zug, listed in the Swiss commercial register since 2018 (UID CHE-163.192.615).
Board members & signatories
- Robert Aleksandrowicz — Präsident des Verwaltungsrates
- Michèle Kellerhals — Mitglied des Verwaltungsrates
- Magdalena Krol — Mitglied des Verwaltungsrates
Registered purpose
Zweck der Gesellschaft sind die Beratung, Forschung, Entwicklung und der Vertrieb in den Bereichen Biochemie, Biotechnologie, Kosmetik, Medizin und Pharmakologie sowie das Halten und Verwalten von geistigen Eigentumsrechten; buchhalterische und administrative Dienstleistungen, Übernahme und Vertretung anderer Gesellschaften, Führung und Verwaltung von gleichartigen Betrieben, und im allgemeinen Au…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What Cellis does
OFFERING
Cellis AG develops a platform technology known as Macrophage Drug Conjugate (MDC) aimed at treating solid tumors. This technology utilizes the TRAIN mechanism for targeted delivery of therapeutic compounds directly into cancer cells, leading to cell death and tumor reduction. The company is preparing to advance its technology to first-in-human clinical trials in Q4 2026.
Unlock the full analysis →Similar companies
- Clear Solutions Laboratories AG — Biotechnology · Basel
- CELLnTEC advanced cell systems AG — Biotechnology · Bern
- NewBiologix AG — Biotechnology · Epalinges
- BioConcept AG — Life Sciences Services (CRO / Consulting) · Allschwil
- System Biologie AG — Biotechnology · Wollerau
- Cerbios-Pharma SA — Pharmaceuticals · Barbengo
Find every biotechnology company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned biotechnology companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime